Attitudes Toward Use of an APOL1 Genetic Testing Chatbot in Living Kidney Donor Evaluation: A Focus Group Study
Fuente:
Wiley Open Access
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Veröffentlicht: |
Wiley
2024
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1867020162376400896 |
|---|---|
| author | James L. Rogers Jessica Gacki‐Smith Rochell Yacat Catherine Wicklund Debra Duquette John Friedewald Matthew Cooper Alexander Gilbert Akansha Agrawal Elisa J. Gordon |
| author_facet | James L. Rogers Jessica Gacki‐Smith Rochell Yacat Catherine Wicklund Debra Duquette John Friedewald Matthew Cooper Alexander Gilbert Akansha Agrawal Elisa J. Gordon James L. Rogers Jessica Gacki‐Smith Rochell Yacat Catherine Wicklund Debra Duquette John Friedewald Matthew Cooper Alexander Gilbert Akansha Agrawal Elisa J. Gordon |
| collection | Wiley Open Access |
| contents | Attitudes Toward Use of an APOL1 Genetic Testing Chatbot in Living Kidney Donor Evaluation: A Focus Group Study James L. Rogers Jessica Gacki‐Smith Rochell Yacat Catherine Wicklund Debra Duquette John Friedewald Matthew Cooper Alexander Gilbert Akansha Agrawal Elisa J. Gordon Clinical Transplantation ABSTRACTBackgroundLiving kidney donor (LKD) candidates of African ancestry are increasingly asked to undergo Apolipoprotein L1 (APOL1) genetic testing during the donor evaluation process to better understand their risk of kidney disease. LKD candidates’ attitudes about using a clinical chatbot on APOL1 remain unknown. This study builds on prior work to culturally adapt the Gia® (Genetic Information Assistant) chatbot on APOL1 by assessing donor, recipient, and community member attitudes about the Gia chatbot for enhancing the integration of APOL1 testing into the LKD clinical evaluation workflow.MethodsThis study involved focus groups and a post‐focus group survey in two US cities about the APOL1 Gia chatbot. Qualitative data were analyzed via thematic analysis, and descriptive statistics were used for demographic data.ResultsWe conducted 10 focus groups including 54 participants (25 LKDs, 23 community members, and 6 living donor kidney transplant recipients of African ancestry). Five themes emerged: (1) participants supported LKD candidates using the Gia chatbot before the nephrologist clinic visit, (2) participants were interested in undergoing APOL1 testing after using Gia, (3) APOL1 testing costs may influence LKD candidates’ willingness to get tested, (4) patients of African ancestry may hold varying preferences for using chatbots in the healthcare setting, and (5) individual‐level barriers may limit the use of Gia in the healthcare setting.ConclusionsIndividuals of African ancestry were highly receptive to integrating the APOL1 chatbot into LKD candidate clinical evaluation, which bodes well for integrating chatbots into the APOL1 clinical genetic testing process. 10.1111/ctr.70026 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| doi_str_mv | 10.1111/ctr.70026 |
| format | Artículo Open Access |
| id | wiley_oa_10_1111_ctr_70026 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Attitudes Toward Use of an APOL1 Genetic Testing Chatbot in Living Kidney Donor Evaluation: A Focus Group Study James L. Rogers Jessica Gacki‐Smith Rochell Yacat Catherine Wicklund Debra Duquette John Friedewald Matthew Cooper Alexander Gilbert Akansha Agrawal Elisa J. Gordon Clinical Transplantation Attitudes Toward Use of an APOL1 Genetic Testing Chatbot in Living Kidney Donor Evaluation: A Focus Group Study James L. Rogers Jessica Gacki‐Smith Rochell Yacat Catherine Wicklund Debra Duquette John Friedewald Matthew Cooper Alexander Gilbert Akansha Agrawal Elisa J. Gordon Clinical Transplantation ABSTRACTBackgroundLiving kidney donor (LKD) candidates of African ancestry are increasingly asked to undergo Apolipoprotein L1 (APOL1) genetic testing during the donor evaluation process to better understand their risk of kidney disease. LKD candidates’ attitudes about using a clinical chatbot on APOL1 remain unknown. This study builds on prior work to culturally adapt the Gia® (Genetic Information Assistant) chatbot on APOL1 by assessing donor, recipient, and community member attitudes about the Gia chatbot for enhancing the integration of APOL1 testing into the LKD clinical evaluation workflow.MethodsThis study involved focus groups and a post‐focus group survey in two US cities about the APOL1 Gia chatbot. Qualitative data were analyzed via thematic analysis, and descriptive statistics were used for demographic data.ResultsWe conducted 10 focus groups including 54 participants (25 LKDs, 23 community members, and 6 living donor kidney transplant recipients of African ancestry). Five themes emerged: (1) participants supported LKD candidates using the Gia chatbot before the nephrologist clinic visit, (2) participants were interested in undergoing APOL1 testing after using Gia, (3) APOL1 testing costs may influence LKD candidates’ willingness to get tested, (4) patients of African ancestry may hold varying preferences for using chatbots in the healthcare setting, and (5) individual‐level barriers may limit the use of Gia in the healthcare setting.ConclusionsIndividuals of African ancestry were highly receptive to integrating the APOL1 chatbot into LKD candidate clinical evaluation, which bodes well for integrating chatbots into the APOL1 clinical genetic testing process. 10.1111/ctr.70026 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| title | Attitudes Toward Use of an APOL1 Genetic Testing Chatbot in Living Kidney Donor Evaluation: A Focus Group Study |
| topic | Clinical Transplantation |
| url | https://onlinelibrary.wiley.com/doi/10.1111/ctr.70026 |